Prothrombin G20210A (Factor II) Mutation
Prothrombin G20210A (Factor II) Mutation Detection, EDTA Blood Price
The Prothrombin G20210A mutation is found in the FII gene in the body. This mutation affects blood clotting by increasing the levels of prothrombin, a protein involved in forming clots, and increases the risk of developing blood clots. Understanding this mutation helps in assessing the risk of venous thrombosis and informing appropriate treatment decisions. The Prothrombin G20210A (Factor II) Mutation assay is used to detect the G20210A mutation in the FII gene. This mutation is associated with an increased risk of venous thrombosis, which is the formation of blood clots in the veins. The clinical utility of this assay lies in identifying individuals who may be at higher risk for developing venous thrombosis. It is particularly beneficial for individuals with a personal history of venous thrombosis, those with a family history of the condition, and pregnant women or women taking oral contraceptives who have previously experienced a venous thrombotic event. By identifying individuals with this mutation, appropriate preventive measures and management strategies can be implemented to reduce the risk of future thrombotic events.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.